作者: Richard L. Norton
DOI:
关键词:
摘要: The present invention relates to biocompatible oligomer-polymer compositions for the in situ formation of implants, wherein implants release a bioactive agent, metabolite, or prodrug thereof, at controlled rate. sustained delivery system includes flowable composition containing and an implant thereof. may be injected into tissue whereupon it coagulates become solid gel, monolithic implant. biodegradable, thermoplastic polymer, end-capped oligomeric liquid,